Source: The Lancet Infectious Diseases. Unidade: FMRP
Assunto: CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BABIKER, A. et al. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. The Lancet Infectious Diseases, v. 11, n. 4, p. 273-283, 2011Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(10)70313-3. Acesso em: 14 maio 2024.APA
Babiker, A., Castro nee Green, H., Compagnucci, A., Fiscus, S., Giaquinto, C., Gibbs, D., et al. (2011). First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. The Lancet Infectious Diseases, 11( 4), 273-283. doi:10.1016/S1473-3099(10)70313-3NLM
Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibbs D, Harper L, Harrison L, Hughes HD, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS, Mussi-Pinhata MM. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial [Internet]. The Lancet Infectious Diseases. 2011 ; 11( 4): 273-283.[citado 2024 maio 14 ] Available from: https://doi.org/10.1016/S1473-3099(10)70313-3Vancouver
Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibbs D, Harper L, Harrison L, Hughes HD, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS, Mussi-Pinhata MM. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial [Internet]. The Lancet Infectious Diseases. 2011 ; 11( 4): 273-283.[citado 2024 maio 14 ] Available from: https://doi.org/10.1016/S1473-3099(10)70313-3
